RAPID MICRO BIOSYSTEMS INC RPID
CLASS A COM · Common Stock · CUSIP 75340L104
- SectorTechnology
- IndustryLaboratory Analytical Instruments
- HeadquartersLexington, MA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $3.34.
Trends to Q3 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 54 |
| Q4 2022 | 43 |
| Q1 2023 | 32 |
| Q2 2023 | 25 |
| Q3 2023 | 24 |
| Q4 2023 | 27 |
| Q1 2024 | 24 |
| Q2 2024 | 22 |
| Q3 2024 | 20 |
| Q4 2024 | 20 |
| Q1 2025 | 29 |
| Q2 2025 | 30 |
| Q3 2025 | 29 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2023 | 12 | 6 |
| Q1 2024 | 7 | 11 |
| Q2 2024 | 6 | 10 |
| Q3 2024 | 4 | 10 |
| Q4 2024 | 8 | 4 |
| Q1 2025 | 21 | 8 |
| Q2 2025 | 14 | 10 |
| Q3 2025 | 13 | 11 |
Biggest buyers
| Evernest Financial Advisors, LLC | Added | +156.2k |
| VANGUARD GROUP INC | Added | +60.7k |
| JANE STREET GROUP, LLC | New | +38.1k |
| STATE STREET CORP | Added | +31.6k |
| DIMENSIONAL FUND ADVISORS LP | Added | +15.3k |
| Hudson Bay Capital Management LP | New | +11.5k |
| BlackRock, Inc. | Added | +7.1k |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Added | +6.5k |
| BNP PARIBAS FINANCIAL MARKETS | New | +3.6k |
| GEODE CAPITAL MANAGEMENT, LLC | Added | +608 |
Biggest sellers
| Schonfeld Strategic Advisors LLC | Reduced | -391.1k |
| Informed Momentum Co LLC | Sold out | -170.1k |
| CITADEL ADVISORS LLC | Sold out | -20.8k |
| Mariner, LLC | Sold out | -20.2k |
| XTX Topco Ltd | Reduced | -19.6k |
| MORGAN STANLEY | Reduced | -15.7k |
| UBS Group AG | Reduced | -8.4k |
| NORTHERN TRUST CORP | Reduced | -833 |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | -800 |
| BANK OF AMERICA CORP /DE/ | Reduced | -162 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Bain Capital Life Sciences Fund, L.P. 13G · exempt (held before listing) filed 2026-08-14 | 16.8% |
| Longitude Capital Partners II, LLC 13G · exempt (held before listing) filed 2026-05-15 | 8.6% |
| ARMISTICE CAPITAL, LLC 13G · institution new · filed 2026-08-14 | 7.3% |
Spignesi Robert G. Jr.
13D · may seek influence
new · filed 2025-08-19
Stated purposeThe information set forth or incorporated by reference in Items 3 and 6 of this Statement is incorporated by reference into this Item 4. The Reporting Person intends to continuously review his investment in the Issuer and may in the future determine (1) to acquire additional securities of the Issuer, through open market purchases, private agreements or otherwise, (2) to dispose of all or a portion of the securities of the Issuer owned by him or (3) to take any other available course of action. Notwithstanding anything contained herein, the Reporting Person specifically reserves the right to change his intention with respect to any or all of such matters. In reaching any decision as to his course of action (as well as to the specific elements thereof), the Reporting Person currently expect… Full filing |
6.3% |
| Endeavour Medtech Growth II LP 13G · passive investor filed 2026-02-13 | 5.7% |
Insider purchases and sales in Q3 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q4 2023 | 0 | — | 0 | — | — |
| Q1 2024 | 0 | — | 0 | — | — |
| Q2 2024 | 0 | — | 0 | — | — |
| Q3 2024 | 4 | $141.8k | 0 | — | — |
| Q4 2024 | 1 | $41.4k | 0 | — | — |
| Q1 2025 | 0 | — | 0 | — | — |
| Q2 2025 | 0 | — | 0 | — | — |
| Q3 2025 | 0 | — | 1 | $196.0k | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2025-07-14 | Spignesi Robert G. Jr. PRESIDENT AND CEO, director | Sold | $39.4k11.9k shares |
| 2025-07-11 | Spignesi Robert G. Jr. PRESIDENT AND CEO, director | Sold | $39.5k11.9k shares |
| 2025-07-10 | Spignesi Robert G. Jr. PRESIDENT AND CEO, director | Sold | $39.5k11.6k shares |
| 2025-07-09 | Spignesi Robert G. Jr. PRESIDENT AND CEO, director | Sold | $39.5k11.2k shares |
| 2025-07-08 | Spignesi Robert G. Jr. PRESIDENT AND CEO, director | Sold | $38.0k10.8k shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q3 2025
| Manager | Shares | Change |
|---|---|---|
| Bain Capital Life Sciences Investors, LLC 1.87% of their portfolio | 8.4m $28.2m | Unchanged |
| ABG-WTT Global Life Science Capital Partners GP Ltd 33.06% of their portfolio | 1.8m $6.2m | Unchanged |
| VANGUARD GROUP INC 0.00% of their portfolio | 965.0k $3.2m | Added +60.7k |
| Parkman Healthcare Partners LLC 0.34% of their portfolio | 913.4k $3.1m | Unchanged |
| Schonfeld Strategic Advisors LLC 0.02% of their portfolio | 646.6k $2.2m | Reduced -391.1k |
| Advent International, L.P. 0.04% of their portfolio | 577.8k $1.9m | Unchanged |
| BlackRock, Inc. 0.00% of their portfolio | 483.9k $1.6m | Added +7.1k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 204.7k $683.9k | Added +608 |
| Evernest Financial Advisors, LLC 0.19% of their portfolio | 200.2k $668.8k | Added +156.2k |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 110.2k $368.0k | Reduced -800 |
| STATE STREET CORP 0.00% of their portfolio | 91.5k $305.5k | Added +31.6k |
| ESSEX INVESTMENT MANAGEMENT CO LLC 0.03% of their portfolio | 62.3k $208.2k | Unchanged |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.00% of their portfolio | 58.4k $195.0k | Added +6.5k |
| DIMENSIONAL FUND ADVISORS LP 0.00% of their portfolio | 55.6k $185.7k | Added +15.3k |
| NORTHERN TRUST CORP 0.00% of their portfolio | 47.7k $159.4k | Reduced -833 |
| JANE STREET GROUP, LLC 0.00% of their portfolio | 38.1k $127.4k | New |
| XTX Topco Ltd 0.00% of their portfolio | 22.2k $74.0k | Reduced -19.6k |
| MORGAN STANLEY 0.00% of their portfolio | 20.6k $68.6k | Reduced -15.7k |
| AMERICAN CENTURY COMPANIES INC 0.00% of their portfolio | 16.9k $56.5k | Unchanged |
| Legato Capital Management LLC 0.01% of their portfolio | 14.7k $49.0k | Unchanged |
| Hudson Bay Capital Management LP 0.00% of their portfolio | 11.5k $38.3k | New |
| BNP PARIBAS FINANCIAL MARKETS 0.00% of their portfolio | 3.6k $12.1k | New |
| RESOURCES MANAGEMENT CORP /CT/ /ADV 0.00% of their portfolio | 500 $2.0k | Unchanged |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 300 $990 | Unchanged |
| UBS Group AG 0.00% of their portfolio | 290 $969 | Reduced -8.4k |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 218 $728 | Added +109 |
| SBI Securities Co., Ltd. 0.00% of their portfolio | 17 $57 | Added +2 |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 15 $50 | Reduced -162 |
| CITIGROUP INC 0.00% of their portfolio | 1 $3 | New |